He is a graduate of Shanxi Medical University in China and the University of Rhode Island. His long-term research goals are to advance the understanding of signaling mechanisms that determine cardiac fibroblast function and to devise new therapeutic strategies for cardiac remodeling that should ultimately benefit patients with cardiopulmonary vascular disease. Learn more about Peng Zhang, MD.